$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Detailed explanation of the mechanism of action of Tilorisen (Harcos) and its impact on the central arousal system
2026-02-01 22:25:32
Check Details
Pretomanid’s mechanism of action, pharmacological characteristics and scientific analysis of multi-drug-resistant tuberculosis treatment
2026-02-01 22:25:32
Check Details
Tepotinib produces better response in adenocarcinoma versus non-adenocarcinoma MET exon 14 skipped non-small cell lung cancer
2026-02-01 22:25:32
Check Details
Zanzalintinib plus atezolizumab versus regorafenib in previously treated metastatic colorectal cancer without MSI-H or dMMR tumors
2026-02-01 22:25:32
Check Details
What is the specific usage and dosage of pazopanib/vitant?
2026-02-01 22:25:32
Check Details
When will opicapone be launched in China?
2026-02-01 22:25:32
Check Details
How long does it take to take Fenelidone/Cashenda before you can consider stopping the drug?
2026-02-01 22:25:32
Check Details
Why it is necessary to control the dosage of rasagiline/alzilate
2026-02-01 22:25:32
Check Details
How much does a box of Pimitespib cost now in 2026?
2026-02-01 22:25:32
Check Details
What is the out-of-pocket price of Lynparza/Olaparib tablets in 2026?
2026-02-01 22:25:32
Check Details
What important information is included in the instructions for Platinib/Pujihua?
2026-02-01 22:25:32
Check Details
What is the daily dosage of capmatinib/touradida?
2026-02-01 22:25:32
Check Details
1
2
...
2430
2431
2432
2433
2434
2435
2436
2437
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma